Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
TOMI Environmental Solutions, Inc. is a U.S.-based environmental solutions company operating primarily in the infection prevention, biosecurity, and decontamination industries. The company develops, licenses, and services proprietary disinfection technologies designed to address contamination risks in healthcare, life sciences, pharmaceutical manufacturing, food safety, and defense-related environments. Its business model centers on product sales, equipment leasing, service contracts, and recurring consumables revenue tied to its core technology platform.
The company’s primary revenue driver is its SteraMist® technology, a hydrogen peroxide–based disinfection system used for surface and air decontamination. TOMI is positioned as a specialized provider of environmentally responsible, low-toxicity disinfection solutions that comply with U.S. Environmental Protection Agency standards. Founded in 1997, the company originally focused on environmental remediation services and gradually evolved into a technology-driven disinfection and biosecurity company, particularly following the commercialization of SteraMist in the 2010s.
Business Operations
TOMI conducts operations through integrated product, service, and licensing activities that support its proprietary disinfection platform. The company generates revenue through the sale and leasing of SteraMist® Surface Unit (SSU) equipment, recurring sales of BIT™ solution (its EPA-registered disinfectant), and on-site decontamination services delivered via its service organization. These offerings are sold directly to end users and through distributors, depending on the market and geography.
Operationally, TOMI maintains domestic and international sales capabilities and controls its intellectual property related to ionized hydrogen peroxide (iHP®) technology. The company operates through wholly owned subsidiaries, including TOMI Service Network, Inc., which provides contract-based decontamination and remediation services. TOMI has also established strategic distribution relationships to expand adoption in regulated industries such as pharmaceutical manufacturing and healthcare facilities.
Strategic Position & Investments
TOMI’s strategic direction emphasizes expanding adoption of its iHP-based disinfection technology across regulated and mission-critical environments. Growth initiatives include increasing penetration in life sciences, cleanroom manufacturing, and hospital infection control, as well as expanding recurring revenue from consumables and service contracts. The company has focused on organic growth rather than large-scale acquisitions, prioritizing technology validation and regulatory compliance.
The company has invested in expanding its intellectual property portfolio and in developing next-generation applications of SteraMist for emerging biosecurity needs. TOMI has also pursued targeted international expansion through distribution agreements and localized partnerships, particularly in regions with growing pharmaceutical manufacturing capacity. No material conflicting data is reported regarding major acquisitions; activity has primarily involved internal investment and partnership-based market entry.
Geographic Footprint
TOMI is headquartered in North America, with its corporate offices and primary operations located in the United States. The company serves customers across the U.S. in healthcare, pharmaceutical, food processing, and government-related sectors, which collectively represent its largest revenue base.
Internationally, TOMI has established a market presence in Europe, Asia, and parts of the Middle East through distributors, partners, and localized service capabilities. While international markets currently represent a smaller share of total revenue compared to domestic operations, they are considered strategic growth regions due to increasing regulatory emphasis on infection prevention and clean manufacturing environments.
Leadership & Governance
TOMI is led by an executive team with experience spanning environmental services, life sciences, and regulated industrial markets. Leadership strategy emphasizes regulatory compliance, intellectual property protection, and long-term adoption of environmentally responsible disinfection technologies. The company operates under a board and governance framework typical of U.S. publicly traded small-cap companies.
Key executives identified in public filings include:
- Dr. Halden Shane – Chief Executive Officer
- Rene Garza – Chief Financial Officer
- Todd T. Weisberg – Chief Commercial Officer
- E.J. Shane – Founder and Executive Chairman
Public disclosures consistently emphasize a leadership philosophy centered on science-driven product validation, disciplined capital management, and expansion of recurring revenue streams. Where executive role descriptions vary slightly across reporting periods, the data is otherwise consistent based on available public sources.